Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

“Phardiacare” Program for Improved Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Patients in Community Health Centers

Author(s): Ferna Putri Pradhyta, Ratu Ayu Dewi Sartika and Rani Sauriasari*

Volume 19, Issue 7, 2023

Published on: 02 February, 2023

Article ID: e301122211381 Pages: 8

DOI: 10.2174/1573399819666221130104225

Price: $65

Abstract

Background: The role of pharmacists in middle-income countries such as Indonesia is still not optimal. In this study, we developed a program called “Phardiacare”, a specific pharmacist-led program for Type 2 diabetes mellitus (T2DM) patients.

Objective: The objective of this study is to assess the effectiveness of the application of the “Phardiacare” program in improving medication adherence and clinical outcomes in T2DM patients.

Methods: The study was quasi-experimental, with a pretest-posttest design, and was conducted prospectively from July to October 2019 at the Matraman and Jatinegara District Health Center, Jakarta, Indonesia. The study comprised 33 T2DM patients in an intervention group (IG) who received the “Phardiacare” program and 33 patients in a control group (CG). Assessment was performed of HbA1c, FBG, LDL, HDL, total cholesterol, triglycerides, and blood pressure.

Results: HbA1c after intervention in the IG was lower than that of the CG (p <0.05). Intra-group mean differences showed improvement in the clinical parameters of FBG, triglycerides, and diastolic blood pressure in the IG (p <0.05), but not in the CG. Other clinical parameters did not show significant improvement. The results of the multivariate analysis showed that the “Phardiacare” program had a 16 times greater effect in reducing levels of HbA1c in the IG [95% CI 3.995:67.113, p <0.001] compared to the CG, even after controlling for confounding variables.

Conclusion: The “Phardiacare” program was effective in improving patient medication adherence by decreasing HbA1c and FBG, but it did not have a significant effect on LDL, HDL, total cholesterol, and systolic blood pressure. Therefore, the implementation of Phardiacare program in the management of chronic diseases, especially T2DM, should be considered.

[1]
Shareef J, Fernandes J, Samaga L. Evolving role of clinical pharmacist in the management of diabetes mellitus. Int J Res Med Sci 2015; 3(6): 1305-8.
[http://dx.doi.org/10.18203/2320-6012.ijrms20150136]
[2]
Butt M, Mhd Ali A, Bakry MM, Mustafa N. Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: A randomised controlled study. Saudi Pharm J 2016; 24(1): 40-8.
[http://dx.doi.org/10.1016/j.jsps.2015.02.023] [PMID: 26903767]
[3]
IDF. IDF Diabetes Atlas. 2017. Available from: www.diabetesatlas.org
[4]
Kementerian Kesehatan Republik Indonesia. HASIL UTAMA RISKESDAS 2018 Main Result of Basic Heatlh Research 2018. Available from: www.depkes.go.id/resources/download/infoterkini/materi_rakorpop_2018/HasilRiskesdas2018.pdf
[5]
World Health Organization - diabetes country profiles 2016. Available from: https://www.who.int/publications/m/item/diabetes-idncountry- profile-indonesia-2016
[6]
Polonsky W, Henry R. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence 2016; 10: 1299-307.
[http://dx.doi.org/10.2147/PPA.S106821] [PMID: 27524885]
[7]
Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci 2011; 3(9): 418-23.
[8]
Pusat Promosi Kesehatan, Departemen Kesehatan Republik Indonesia. Panduan Pelatihan Komunikasi Perubahan Perilaku Untuk KIBBLA 2014 [Behavior Change Communication Training Guide For KIBBLA 2014]. http://perpustakaan.depkes.go.id:8180/handle/123456789/2088
[9]
Direktorat Jenderal dan Bina Kefarmasian, Departemen Kesehatan Republik Indonesia. Pedoman Konseling Pelayanan Kefarmasian di Sarana Kesehatan [Counseling Guidelines for Pharmaceutical Care in Health Facilities]. 2007. Available from: https://fdokumen.com/document/pedoman-konseling-pelayanankefarmasian- di-sarana-pio-buku-pedoman-konseling.html?page=1
[10]
Shareef J, Fernandes J. Evaluating the effect of pharmacist’s delivered counseling on medication adherence and glycemic control in patients with diabetes mellitus. J Diabetes Metab 2016; 7(3): 1-4.
[http://dx.doi.org/10.4172/2155-6156.1000654]
[11]
Sauriasari R, Hening WN, Sartika RAD. Effect of hospital pharmacist counseling on clinical outcomes of type 2 diabetes mellitus outpatients. J Res Pharm Pract 2019; 8(3): 155-61.
[http://dx.doi.org/10.4103/jrpp.JRPP_19_67] [PMID: 31728347]
[12]
Abdulghani KH, Aseeri MA, Mahmoud A, Abulezz R. The impact of pharmacist-led medication reconciliation during admission at tertiary care hospital. Int J Clin Pharm 2018; 40(1): 196-201.
[http://dx.doi.org/10.1007/s11096-017-0568-6] [PMID: 29248986]
[13]
Feskens EJM, Sluik D, van Woudenbergh GJ. Meat consumption, diabetes, and its complications. Curr Diab Rep 2013; 13(2): 298-306.
[http://dx.doi.org/10.1007/s11892-013-0365-0] [PMID: 23354681]
[14]
Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes. Metab Syndr Obes Targets Ther 2014; 7: 587-91.
[15]
Fareed M, Salam N. Life style related risk factors of type 2 diabetes mellitus and its increased prevalence in Saudi Arabia: A brief review. Saudi Med J 2010; 31(7): 768-74.
[16]
World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus 2011.https://apps.who.int/iris/bitstream/handle/10665/70523/WHO_NMH_CHP_CPM_11.1_eng.pdf Available from
[PMID: 21820751]
[17]
Abdullah A, Alkandari A, Longenecker JC, et al. Glycemic control in Kuwaiti diabetes patients treated with glucose-lowering medication. Prim Care Diabetes 2020; 14(4): 311-6.
[http://dx.doi.org/10.1016/j.pcd.2019.12.001] [PMID: 31911041]
[18]
American Diabetes Association. Facilitating behavior change and well-being to improve health outcomes: Standards of medical care in diabetes-2022. Diabetes Care 2018; 45(S1): S60-82.
[19]
P.D. R. Common medications used by patients with type 2 diabetes mellitus: What are their effects on the lipid profile? Cardiovasc Diabetol 2016; 15: 95.
[20]
Pereira RM, Moura LP, Muñoz VR, et al. Molecular mechanisms of glucose uptake in skeletal muscle at rest and in response to exercise. Motriz 2017; 23(spe)e101609
[http://dx.doi.org/10.1590/s1980-6574201700si0004]
[21]
Presley B, Groot W, Pavlova M. Pharmacy-led interventions to improve medication adherence among adults with diabetes: A systematic review and meta-analysis. Res Social Adm Pharm 2019; 15(9): 1057-67.
[http://dx.doi.org/10.1016/j.sapharm.2018.09.021] [PMID: 30685443]
[22]
Waheed P, Naveed AK, Farooq F. Levels of inflammatory markers and their correlation with dyslipidemia in diabetics. J Coll Physicians Surg Pak 2009; 19(4): 207-10.
[PMID: 19356332]
[23]
Hirano T. Pathophysiology of diabetic dyslipidemia 2018. J Atherosclerosis Thrombosis 2018; 25(9): 771-82.
[http://dx.doi.org/10.5551/jat.RV17023]
[24]
Yanai H, Hirowatari Y, Yoshida H. Diabetic dyslipidemia: evaluation and mechanism. Glob Health Med 2019; 1(1): 30-5.
[25]
Ohishi M. Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res 2018; 41(6): 389-93.
[http://dx.doi.org/10.1038/s41440-018-0034-4] [PMID: 29556093]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy